The board has recommended a final dividend payout of Rs 1.50 per share. In FY23, Biocon’s revenue grew almost 37% to Rs 11,174 crore, while its net profit fell nearly 29% to Rs 463 crore. The biosimilars business segment more than doubled its year-on-year revenue to INR2,102 crore in Q4 2022.
Vishal Mega Mart promoter to sell 10% stake worth Rs 5,057 crore via block deal: Report
Vishal Mega Mart’s promoter, Samayat Services LLP, plans to sell 10% equity via block deals worth ₹5,057 crore at a 12% discount. Despite this, shares